| mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
Irinotecan |
CCLE |
pan-cancer |
AAC |
0.0044 |
0.9 |
| mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.0031 |
0.9 |
| mRNA |
ML203 |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
0.0028 |
0.9 |
| mRNA |
JW-7-52-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0042 |
0.9 |
| mRNA |
BRD-K04800985 |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
| mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
| mRNA |
tretinoin:carboplatin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |